Debarment, Restriction, or Inability of Investigator. Institution and Investigator will immediately notify Gilead in writing if during the course of the Trial, Investigator: (i) is debarred, disqualified or receives notification of any investigation by his/her professional governing body, any regulatory authority or other government authority; (ii) receives notification of any restriction on his/her clinical privileges at Institution; (iii) is sanctioned by any regulatory authorities or other governmental authorities; (iv) terminates or has been terminated from his/her employment or other contractual relationship with the Institution; or (v) otherwise becomes unfit, unable or unwilling to fulfill his/her obligations under this Agreement. In the event of any of the foregoing, Institution will ensure that the original Investigator will continue to comply with the terms of this Agreement. If requested by Gilead, Institution and Investigator will cooperate to find a suitable replacement investigator or transition the Trial to another institution in a timely manner so as not to interrupt the Trial.
Appears in 4 contracts
Samples: Clinical Trial Agreement, Clinical Trial Agreement, Clinical Trial Agreement
Debarment, Restriction, or Inability of Investigator. Institution and Investigator will immediately notify Gilead in writing if if, during the course of the Trial, the Institution becomes aware the Investigator: (i) is debarred, disqualified or receives notification of any investigation by his/her professional governing body, any regulatory authority or other government authority; (ii) receives notification of any restriction on his/her clinical privileges at Institution; (iii) is sanctioned by any regulatory authorities or other governmental authorities; (iv) terminates or has been terminated from his/her employment or other contractual relationship with the Institution; or (v) otherwise becomes unfit, unable or unwilling to fulfill his/her obligations under this Agreement. In If any circumstances make it impossible for Investigator to continue the event of any of the foregoingTrial, Institution will ensure that the original Investigator will continue to comply cooperate with the terms of this Agreement. If requested by Gilead, Institution and Investigator will cooperate Gilead to find a suitable replacement investigator or transition the Trial to another institution in a timely manner so as not to interrupt the Trial.
Appears in 2 contracts